We use cookies to help improve our website and personalise your experience. To find out more about how to manage these cookies, please see our cookie policy.
We are extremely delighted and proud to win the Business of the Year with turnover above £5 million category at the Rochdale Business Awards hosted at the Rochdale Town Hall on November 4, 2016. We were commended for our growth, employee development and overall business performance.
BES have recently completed the concept and scheme design of a flagship production facility for one of our key clients, who specialise in research, development and manufacturing of a broad range of treatments worldwide.
​For the third consecutive year we are pleased to be a premium sponsor at The International Society for Pharmaceutical Engineering (ISPE) UK Affiliate Annual Conference, which will be held in the vibrant city of Leeds on the 10th of November. The event will bring together pharmaceutical engineering professionals from all across the UK for industry focused conferences and networking. With a comprehensive programme focusing on “Technologies for the 21st Centuryâ€, the 2016 ISPE UK Affiliate Annual Conference is one of the key industry events to attend this year. This is a great opportunity for industry experts to share best practices and further develop their supply chain knowledge through meeting exhibitors. We look forward to meeting conference affiliates and dinner attendees!
This year we are celebrating 8 years of continuous membership within Building Engineering Services Association (BESA), formerly the HVCA. Established in 1904, BESA is the UK's leading trade organisation for companies that design, install, commission, maintain, control and manage engineering systems and services in buildings.
We are pleased to wish you a happy National Women in Engineering Day! This is the third year the event has been held to celebrate the achievements of women in engineering and encourage more girls to consider engineering as a career.
BES are currently constructing a new research and development facility on an existing brownfield site in Hull. As a part of the planning considerations we have been working in partnership with the client's Ecological Clerk of Works (ECW) to create a very specific type of landscaping scheme with an open mosaic and invertebrate attractive habitat.
Our company has grown from strength to strength since it was established in 2002, now employing well over 100 staff and with an anticipated turnover in excess of £30million this year. Our customer base has continued to expand and our commitment to 'Exceeding Expectations' is borne out by the growth in repeat business clients who now provide over 75% of our workload.
We have recently completed the remodelling of an existing space into a classified ISO7 and ISO8 production facility for a leading Biopharmaceutical CDMO in North East of England. We provided a full turnkey service from concept stage through to detailed design and construction including strip out and demolition, construction of new cleanrooms, HVAC and electrical services, commissioning and validation. Our turnkey service was also evident in our health and safety responsibilities whereby we also fulfilled the roles of Principal Designer and Principal Contractor under CDM 2015.
We have been selected by Tadmur Trading, a repeat business customer for BES, to support them with the provision of cleanroom consultation and design services for a project at the prestigious hi-tech Sidra Hospital in Doha, Qatar. The scope of work involves the remodelling of the existing facilities in order to produce three new validated research and support areas. These new cleanrooms will be designed to the highest standards, complying with US Pharmacopeia 797 guide.
We are pleased to report the successful completion of the fast track refurbishment of an existing 2,200m2 laboratory and office for a Blue Chip customer at Chesterford Science Park. The upgraded facility will be used as a temporary home for the relocation of approximately 150 scientists to Cambridge, pending the completion of their new facility, and therefore the project had to be completed at record pace to ensure that medicines can continue to be developed during this transition phase.